John Feeney
Adult Medicine · Murrieta, CANPI 1528049475
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 97 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations.
Across 97 payments — averaging $19.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$285
- Pfizer$186
- GSK$174
- AbbVie$141
- Amgen$134
- Collegium Pharmaceutical, Inc.$107
- plus $855 from 25 others
What the payments were for
- Food & beverage$1,882100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 13 | $285 |
| Pfizer | 17 | $186 |
| GSK | 5 | $174 |
| AbbVie(2 entities) | 6 | $141 |
| Amgen | 7 | $134 |
| Collegium Pharmaceutical, Inc. | 5 | $107 |
| Merck | 5 | $84 |
| Exact Sciences | 4 | $83 |
| Lilly USA, LLC | 5 | $77 |
| Hologic Sales And Service, LLC | 4 | $76 |
| Medtronic(2 entities) | 2 | $50 |
| Verity Pharmaceuticals Inc. | 2 | $49 |
| Mannkind Corporation | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 2 | $33 |
| Boston Scientific | 1 | $33 |
| Astellas Pharma US Inc | 1 | $32 |
| Inspire Medical Systems, Inc. | 1 | $31 |
| Boehringer Ingelheim | 2 | $31 |
| Aimmune Therapeutics, Inc. | 1 | $26 |
| Edwards Lifesciences | 1 | $24 |
| Antares Pharma, Inc. | 1 | $22 |
| Optinose US, Inc. | 1 | $22 |
| Avanir Pharmaceuticals, Inc. | 1 | $22 |
| Tolmar, Inc. | 1 | $20 |
| Phadia US Inc. | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Novo Nordisk | 1 | $12 |
| Amarin Pharma, Inc. | 1 | $12 |
How this compares
$1,882 in reported general payments places this provider in the 80th percentile of 221 adult medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 89 | $101,842 |
| Xtampza ErOxycodone Myristate | 23 | $40,966 |
| XareltoRivaroxaban | 32 | $33,147 |
| JanuviaSitagliptin Phosphate | 15 | $24,022 |
| FarxigaDapagliflozin Propanediol | 14 | $20,494 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $11,564 |
| LinzessLinaclotide | 11 | $10,711 |
| Breo ElliptaFluticasone/Vilanterol | 14 | $10,365 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 306 | $9,830 |
| Spiriva RespimatTiotropium Bromide | 11 | $8,575 |
| Wixela InhubFluticasone Propion/Salmeterol | 19 | $5,302 |
| Advair HfaFluticasone Propion/Salmeterol | 12 | $5,128 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 128 | $3,382 |
| Gabapentin | 138 | $3,310 |
| Levothyroxine Sodium | 247 | $2,824 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Paxlovid | $186 | $103,271100 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $107 | $40,96623 claims |
| Johnson & JohnsonXarelto | $14 | $33,14732 claims |
| MerckJanuvia | $84 | $24,02215 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $174 | $21,92928 claims |
| AstraZenecaFarxiga | $285 | $20,49414 claims |
| AbbVieLinzess, Synthroid | $141 | $12,43640 claims |
| Boehringer IngelheimSpiriva Respimat | $31 | $8,57511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 221 adult medicine providers in California.
Other adult medicine in Murrieta
- Michael CurleyMurrieta$2K
- Susan HutchinsonLaguna Hills$1M
- Natalia GuzmanLos Angeles$583K
- Richard FauselRancho Mirage$30K
- Benedicto EstoestaValley Springs$22K
- Antoine DipsiaW. Sacramento$21K
- Patrick WelchArroyo Grande$20K
- Craig BobsonManteca$19K
- Tin WongLos Angeles$18K
- Sofia VaismanWoodland Hills$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.